AGL

NEUTRALEarnings

agilon health, inc.

2026-06-17

Price

$104.67

-7.59%

Score2.0Noise

Signals2/8 DNA1/13 Act · 1/4 Risk

SentimentNEUTRALScore: 7

Volume1.1xvs 20d avg

Analysis

Agilon Health (AGL) is undergoing a healthy -7.59% pullback after a massive post-earnings surge, presenting a textbook case of Institutional Absorption. The stock's structural breakout is supported by a PERFECT_STACK and GOLDEN_CROSS, confirming High-Conviction Price Discovery following a Q1 earnings beat and raised guidance. While the broader RISK_ON regime has sparked a temporary capital rotation toward tech and momentum names amid the U.S.-Iran peace agreement, AGL's robust relative strength (+17.5% vs SPY) suggests buyers will aggressively defend the trend.

Fired Signals

GOLDEN CROSSPERFECT STACKBARGAIN HUNTEREXTENSION

Key Takeaways

Actionable Thesis: The current pullback is a high-conviction buying opportunity supported by PERFECT_STACK and GOLDEN_CROSS technicals following a blowout Q1 earnings report [1.1.7].
Key Risk: Continued sector rotation away from healthcare into high-beta tech names driven by the macro RISK_ON environment.
What to Watch: Price action around the $80.57 line-in-the-sand and upcoming management commentary at the Truist Securities and Citizens Healthcare conferences on June 23-25.

← Back to 2026-06-17 View Full AGL History →Yahoo Finance &nearr;